Grifols S.A. Logo

Grifols S.A.

Leading producer of plasma-derived medicines for patients with rare and chronic diseases.

GRF | MC

Overview

Corporate Details

ISIN(s):
ES0171996087 (+4 more)
LEI:
959800HSSNXWRKBK4N60
Country:
Spain
Address:
Avenida de la Generalitat 152-158, 08174 Sant Cugat del Vallès
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Grifols is a global healthcare company and a leading producer of plasma-derived medicines. Founded in 1909, the company develops, produces, and markets innovative biopharmaceuticals and solutions in transfusion medicine to improve the health and well-being of people worldwide. Its core activities are centered on its expertise in plasma science, serving patients with chronic and rare diseases across various therapeutic areas, including immunology, neurology, and critical care. Grifols provides a range of products and services through its primary divisions: Bioscience, Diagnostic, and Hospital. The company is committed to the highest standards of safety and quality, leveraging scientific innovation to treat diseases and enhance patient lives.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Grifols S.A. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-12 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-06-13 00:00
Director's Dealing
Motivo de la notificación: Persona Estrechamente Vinculada
Spanish 91.4 KB
2025-06-06 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-19 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-16 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-12 17:36
Earnings Release
Grifols anuncia la información financiera del primer trimestre de 2025
Spanish 1.3 MB
2025-05-06 12:54
M&A Activity
Como continuación de la Información Privilegiada presentada por Grifols el 31 d…
Spanish 43.3 KB
2025-05-02 08:04
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas 2025 de Grifols, S.A.
Spanish 137.8 KB
2025-05-02 00:00
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas 2025 de Grifols, S.A.
Spanish 137.8 KB
2025-04-02 13:40
M&A Activity
Brookfield Capital Partners realiza comunicación en relación a noticias de pren…
Spanish 86.2 KB
2025-04-02 11:30
Regulatory News Service
Con respecto a la información publicada en ciertos medios de comunicación.
Spanish 39.1 KB
2025-03-31 08:57
Delisting Announcement
El Consejo de Administración ha aprobado por unanimidad que su filial Grifols B…
Spanish 41.6 KB
2025-03-14 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-03-10 12:55
Legal Proceedings Report
Grifols desea informar sobre cierta información publicada en un medio de comuni…
Spanish 54.6 KB
2025-03-05 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 94.7 KB

Automate Your Workflow. Get a real-time feed of all Grifols S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Grifols S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC

Talk to a Data Expert

Have a question? We'll get back to you promptly.